Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Open Access Highly Access Email this article to a friend

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

Francisco J Esteva*, Carol D Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon, Robert P Thiel, Diana Luftner and Farooq Ghani

Breast Cancer Research 2005, 7:R436-R443 doi:10.1186/bcr1020

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.